8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Neurohormones and heart failure: the importance of aldosterone.

      International Journal of Clinical Practice
      Adaptation, Physiological, Aldosterone, metabolism, physiology, Angiotensin II Type 1 Receptor Blockers, therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Cardiomegaly, etiology, Cardiomyopathies, Endothelium, Vascular, physiopathology, Heart Failure, drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Necrosis, Neurotransmitter Agents, Randomized Controlled Trials as Topic, Vascular Resistance

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Heart failure is a major cause of cardiovascular morbidity and mortality and its incidence is on the increase. The pathophysiology of heart failure is multi-factorial but recent studies suggest that aldosterone plays an important and independent role in its progression. Emerging evidence now suggests that aldosterone exerts renal-independent effects. It binds to its mineralocorticoid receptor to produce direct effects on the myocardium and vasculature, leading to damaging processes such as hypertrophy, necrosis, fibrosis and endothelial dysfunction, factors known to contribute to the pathophysiology of heart failure. Mineralocorticoid receptor antagonists have thus emerged as a new paradigm for the treatment of heart failure. The benefits of these agents on both morbidity and mortality when used in patients with chronic symptomatic heart failure have been demonstrated by recent trials.

          Related collections

          Author and article information

          Comments

          Comment on this article